Edges in Network
| Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | ISG20 |
| Upstream (Parents) |
|---|
| (<<) CD274 → ISG20 |
| (<<) HLA-A → ISG20 |
| (<<) HLA-G → ISG20 |
| (<<) LTB → ISG20 |
| (<<) MAL → ISG20 |
| (<<) MLKL → ISG20 |
| (<<) PLCG2 → ISG20 |
| (<<) PRKCQ → ISG20 |
| (<<) RAC2 → ISG20 |
| (<<) RASSF5 → ISG20 |
| (<<) RHOF → ISG20 |
| (<<) SH2D2A → ISG20 |
| (<<) STAT1 → ISG20 |
| (<<) TNFAIP3 → ISG20 |
| (<<) UBE2L6 → ISG20 |
| (<<) ZBED2 → ISG20 |
| Downstream (Children) |
|---|
| ISG20 → GNG10 (>>) |
| ISG20 → ITPR3 (>>) |
| ISG20 → MOBKL2C (>>) |
| ISG20 → PDIA3 (>>) |
| ISG20 → RXRA (>>) |
| ISG20 → STYK1 (>>) |
| ISG20 → TINF2 (>>) |
| ISG20 → TNFRSF10A (>>) |
